| __timestamp | Ascendis Pharma A/S | BioMarin Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 19698000 | 461543000 |
| Thursday, January 1, 2015 | 40528000 | 634806000 |
| Friday, January 1, 2016 | 66022000 | 661905000 |
| Sunday, January 1, 2017 | 99589000 | 610753000 |
| Monday, January 1, 2018 | 140281000 | 696328000 |
| Tuesday, January 1, 2019 | 191621000 | 715007000 |
| Wednesday, January 1, 2020 | 260904000 | 628116000 |
| Friday, January 1, 2021 | 295867000 | 628793000 |
| Saturday, January 1, 2022 | 379624000 | 649606000 |
| Sunday, January 1, 2023 | 413454000 | 746773000 |
| Monday, January 1, 2024 | 307004000 |
Unleashing the power of data
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, BioMarin Pharmaceutical Inc. and Ascendis Pharma A/S have been at the forefront of this race. Since 2014, BioMarin has consistently outspent Ascendis, with its R&D expenses peaking at approximately 750 million USD in 2023, a 62% increase from 2014. In contrast, Ascendis Pharma has shown a remarkable growth trajectory, with its R&D spending skyrocketing by over 2,000% from 2014 to 2023, reaching around 413 million USD. This dramatic increase underscores Ascendis's aggressive push into the biotech arena. As these two companies continue to innovate, their R&D investments will likely play a pivotal role in shaping the future of biotechnology.
Gilead Sciences, Inc. vs BioMarin Pharmaceutical Inc.: Strategic Focus on R&D Spending
Vertex Pharmaceuticals Incorporated vs BioMarin Pharmaceutical Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Incyte Corporation vs Ascendis Pharma A/S
BioMarin Pharmaceutical Inc. and Ascendis Pharma A/S: A Comprehensive Revenue Analysis
BioMarin Pharmaceutical Inc. vs ACADIA Pharmaceuticals Inc.: Strategic Focus on R&D Spending
BioMarin Pharmaceutical Inc. vs Bausch Health Companies Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for BioMarin Pharmaceutical Inc. and Ligand Pharmaceuticals Incorporated
Analyzing R&D Budgets: BioMarin Pharmaceutical Inc. vs BioCryst Pharmaceuticals, Inc.
BioMarin Pharmaceutical Inc. vs MiMedx Group, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Ascendis Pharma A/S vs Madrigal Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Ascendis Pharma A/S and Rhythm Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and ImmunityBio, Inc.